Mark Pruzanski - Net Worth and Insider Trading
Mark Pruzanski Net Worth
The estimated net worth of Mark Pruzanski is at least $11 Million dollars as of 2024-11-13. Mark Pruzanski is the President & CEO of Intercept Pharmaceuticals Inc and owns about 566,829 shares of Intercept Pharmaceuticals Inc (ICPT) stock worth over $11 Million. Details can be seen in Mark Pruzanski's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Pruzanski has not made any transactions after 2019-12-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Pruzanski
Mark Pruzanski Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Pruzanski owns 2 companies in total, including Intercept Pharmaceuticals Inc (ICPT) , and Equillium Inc (EQ) .
Click here to see the complete history of Mark Pruzanski’s form 4 insider trades.
Insider Ownership Summary of Mark Pruzanski
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ICPT | Intercept Pharmaceuticals Inc | 2019-12-31 | director & President & CEO |
| EQ | Equillium Inc | 2018-10-11 | director |
Mark Pruzanski Latest Holdings Summary
Mark Pruzanski currently owns a total of 1 stock. Mark Pruzanski owns 566,829 shares of Intercept Pharmaceuticals Inc (ICPT) as of December 31, 2019, with a value of $11 Million.
Latest Holdings of Mark Pruzanski
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ICPT | Intercept Pharmaceuticals Inc | 2019-12-31 | 566,829 | 19.00 | 10,769,751 |
Holding Weightings of Mark Pruzanski
Mark Pruzanski Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Pruzanski has made a total of 3 transactions in Intercept Pharmaceuticals Inc (ICPT) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Intercept Pharmaceuticals Inc is the sale of 100 shares on December 31, 2019, which brought Mark Pruzanski around $12,500.
Insider Trading History of Mark Pruzanski
- 1
Mark Pruzanski Trading Performance
GuruFocus tracks the stock performance after each of Mark Pruzanski's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Pruzanski is 36.02%. GuruFocus also compares Mark Pruzanski's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Pruzanski within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Pruzanski's insider trading performs compared to the benchmark.
Performance of Mark Pruzanski
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.99 | | | | | |
| Relative Return to S&P 500(%) | 0.75 | | | | | |
Mark Pruzanski Ownership Network
Ownership Network List of Mark Pruzanski
Ownership Network Relation of Mark Pruzanski
Mark Pruzanski Owned Company Details
What does Intercept Pharmaceuticals Inc do?
Who are the key executives at Intercept Pharmaceuticals Inc?
Mark Pruzanski is the director & President & CEO of Intercept Pharmaceuticals Inc. Other key executives at Intercept Pharmaceuticals Inc include EVP & Chief Financial Officer Andrew Saik , President & R&D and CMO M Michelle Berrey , and Chief Accounting Officer Rocco Venezia .
Intercept Pharmaceuticals Inc (ICPT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Intercept Pharmaceuticals Inc (ICPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intercept Pharmaceuticals Inc (ICPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Intercept Pharmaceuticals Inc (ICPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intercept Pharmaceuticals Inc Insider Transactions
Mark Pruzanski Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Pruzanski. You might contact Mark Pruzanski via mailing address: C/o Intercept Pharmaceuticals, Inc., 18 Desbrosses St., New York Ny 10013.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
